Calidi Biotherapeutics (CLDI) Operating Leases (2022 - 2025)
Calidi Biotherapeutics' quarterly Operating Leases came in at $277000.0 in Q4 2025, down 84.99% year-on-year from $1.8 million in Q4 2024, and down 56.72% quarter-over-quarter from $640000.0 in Q3 2025.
Calidi Biotherapeutics has reported Operating Leases for 4 years, with the latest figure at $277000.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases fell 84.99% year-over-year to $277000.0; the trailing twelve-month figure through Dec 2025 stood at $277000.0 (down 84.99% YoY), and the FY2025 full-year result was $277000.0, down 84.99% from the prior year.
- Operating Leases for Q4 2025 stood at $277000.0, down from $640000.0 in the prior quarter.
- The five-year high for Operating Leases was $3.8 million in Q1 2023, with the low at $152000.0 in Q3 2022.
- Average Operating Leases over 4 years is $1.9 million, with a median of $2.0 million recorded in 2024.
- Year-over-year, Operating Leases surged 2024.34% in 2023 and slumped 84.99% in 2025.
- Tracing CLDI's Operating Leases over 4 years: stood at $305000.0 in 2022, then soared by 895.74% to $3.0 million in 2023, then slumped by 39.25% to $1.8 million in 2024, then tumbled by 84.99% to $277000.0 in 2025.
- The last three Operating Leases figures came in at $277000.0 (Q4 2025), $640000.0 (Q3 2025), and $993000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 277,000.00 |
| Sep 30, 2025 | 640,000.00 |
| Jun 30, 2025 | 993,000.00 |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.76 Mn |
| Dec 31, 2023 | 3.04 Mn |
| Sep 30, 2023 | 3.23 Mn |
| Jun 30, 2023 | 3.55 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 305,000.00 |
| Sep 30, 2022 | 152,000.00 |